Total submissions: 7
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Ce |
RCV001729398 | SCV006097929 | likely benign | not provided | 2025-05-01 | criteria provided, single submitter | clinical testing | PHF6: BS2 |
| Fulgent Genetics, |
RCV000634411 | SCV005683320 | likely benign | Borjeson-Forssman-Lehmann syndrome | 2024-04-26 | criteria provided, single submitter | clinical testing | |
| Labcorp Genetics |
RCV000634411 | SCV000755714 | likely benign | Borjeson-Forssman-Lehmann syndrome | 2024-04-08 | criteria provided, single submitter | clinical testing | |
| Prevention |
RCV003407522 | SCV004114839 | uncertain significance | PHF6-related disorder | 2024-04-17 | no assertion criteria provided | clinical testing | The PHF6 c.487C>T variant is predicted to result in the amino acid substitution p.Arg163Cys. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.013% of alleles in individuals of European (Non-Finnish) descent in gnomAD, including in 4 hemizygous individuals. Although we suspect this variant may possibly be benign, at this time its clinical significance is uncertain due to the absence of conclusive functional and genetic evidence. |
| Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001729398 | SCV001980244 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
| Clinical Genetics, |
RCV001729398 | SCV001979072 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
| ITMI | RCV000121804 | SCV000086002 | not provided | not specified | 2013-09-19 | no assertion provided | reference population |